David A. Siegel Nkarta, Inc. Transaction History

Two Sigma Advisers, LP

$47 Billion
Q3 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Nkarta, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 192,900 shares of NKTX stock, worth $360,723. This represents 0.0% of its overall portfolio holdings.

Number of Shares

192,900

Previous 88,400 118.21%

Holding current value

$360,723

Previous $146,000 173.29%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$1.67 - $2.37 $174,515 - $247,665	104,500 Added 118.21%	192,900 $399,000
Q2 2025 Aug 14, 2025	SELL	$1.51 - $2.22 $48,169 - $70,818	-31,900 Reduced 26.52%	88,400 $146,000
Q1 2025 May 15, 2025	BUY	$1.37 - $2.53 $23,016 - $42,504	16,800 Added 16.23%	120,300 $221,000
Q4 2024 Feb 14, 2025	BUY	$2.17 - $4.34 $224,595 - $449,190	103,500 New	103,500 $257,000
Q2 2024 Aug 14, 2024	BUY	$5.27 - $10.82 $76,942 - $157,972	14,600 New	14,600 $86,000

Q4 2023 Feb 14, 2024	SELL	$1.31 - $6.6 $88,294 - $444,840	-67,400 Reduced 86.3%	10,700 $70,000
Q3 2023 Nov 14, 2023	SELL	$1.39 - $2.29 $4,865 - $8,015	-3,500 Reduced 4.29%	78,100 $108,000
Q2 2023 Aug 14, 2023	SELL	$2.19 - $5.17 $104,244 - $246,092	-47,600 Reduced 36.84%	81,600 $178,000
Q1 2023 May 15, 2023	SELL	$3.37 - $6.3 $200,515 - $374,850	-59,500 Reduced 31.53%	129,200 $458,000
Q4 2022 Feb 14, 2023	SELL	$5.14 - $14.35 $192,750 - $538,125	-37,500 Reduced 16.58%	188,700 $1.13 Million
Q3 2022 Nov 14, 2022	BUY	$12.27 - $18.39 $769,329 - $1.15 Million	62,700 Added 38.35%	226,200 $2.98 Million
Q2 2022 Aug 15, 2022	BUY	$7.77 - $19.44 $1.27 Million - $3.18 Million	163,500 New	163,500 $2.01 Million
Q1 2022 May 16, 2022	SELL	$8.66 - $14.99 $198,314 - $343,271	-22,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.79 - $26.88 $292,891 - $615,552	22,900 New	22,900 $352,000

Others Institutions Holding NKTX

# of Institutions

128

Shares Held

58.1M

Call Options Held

Put Options Held

58.3K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $91M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account